SLC5A2 and type 2 diabetes mellitus: Renal-specific sodium-glucose cotransporter 2 (SGLT2) in proximal tubules performs approximately 90% of active renal glucose reabsorption; SGLT2 was considered a therapeutic target for anti-hyperglycemia by promoting glycosuria, which was considered a novel therapeutic strategy for type 2 diabetes (8–10).